Medical Decision Modeling Inc.

MDM was founded in 1996. To date, MDM has been awarded $2M in competitively-awarded grants to research and develop its innovative software products - $1.9M from the National Institutes of Health (NIH) and $100,000 from the State of Indiana's 21st Century Research and Technology Fund. MDM is a revenue-generating and profitable company that has successfully commercialized its NIH research, serving such prestigious clients as Bayer Corporation, Boehringer Ingelheim Pharmaceuticals, Eli Lilly and Company, EXACT Sciences Corporation, Guidant Corporation, Indiana University Medical Center, MedImmune, Inc., and Vanderbilt University Medical Center. Specifically, MDM has performed modeling research in the following disease areas (alphabetically): acute bacterial sinusitis, acute coronary syndrome, acute exacerbations of chronic bronchitis, attention deficit hyperactivity disorder, benign prostatic hyperplasia, bipolar disorder, breast cancer, colorectal cancer, community-acquired pneumonia, diabetes, duodenal ulcers, esophageal varices in cirrhosis, generalized anxiety disorder, hepatitis C, hypertension, major depressive disorder, non-Hodgkins lymphoma, non-small cell lung cancer, osteoporosis, skin and skin structure infections, stress urinary incontinence, stroke, total knee replacement, and urinary tract infections.